WallStreetZen

NASDAQ: SYNH
Syneos Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for SYNH

Based on 7 analysts offering 12 month price targets for Syneos Health Inc.
Min Forecast
$75.00-22.13%
Avg Forecast
$90.86-5.66%
Max Forecast
$104.00+7.98%

Should I buy or sell SYNH stock?

Based on 7 analysts offering ratings for Syneos Health Inc.
Strong Buy
Strong Buy
4 analysts 57.14%
Buy
2 analysts 28.57%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

SYNH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Credit Suisse
Top 27%
74
BuyMaintains$100.00+3.83%2021-08-10
Barclays
Top 21%
80
HoldMaintains$102.00+5.91%2021-07-13
Truist Securities
Top 3%
98
Strong BuyMaintains$104.00+7.98%2021-06-02
Mizuho
Top 9%
92
Strong BuyMaintains$90.00-6.55%2021-04-30
KeyBanc
Top 7%
94
Strong BuyMaintains$90.00-6.55%2021-03-08
Anonymous
Credit Suisse
BuyMaintains$75.00-22.13%2020-12-07
Goldman Sachs
Top 27%
74
Strong BuyUpgrades$75.00-22.13%2020-10-01

1 of 1

Forecast return on equity

Is SYNH forecast to generate an efficient return?
Company
18.47%
Industry
47.75%
Market
2,530.71%
SYNH's Return on Equity is forecast to be low in 3 years (18.47%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is SYNH forecast to generate an efficient return on assets?
Company
7.46%
Industry
15.95%
Market
1,237.48%
SYNH is forecast to generate lower Return on Assets (7.46%) than the US Diagnostics & Research industry average (15.95%)
Forecast

SYNH earnings per share forecast

What is SYNH's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$3.87+71.24%
Avg 2 year Forecast
$4.55+101.33%
Avg 3 year Forecast
$5.07+124.34%
SYNH's earnings are forecast to grow at an exceptional rate of 31.42% per year
Forecast

SYNH revenue forecast

What is SYNH's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$5.2B+10.89%
Avg 2 year Forecast
$5.7B+20.21%
Avg 3 year Forecast
$6.1B+28.21%
SYNH's revenue is forecast to grow at a rate of 8.74% per year, which is not exceptional
Forecast

SYNH earnings growth forecast

How is SYNH forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
31.42%
Industry
16.12%
Market
18.62%
SYNH's earnings are forecast to grow faster (31.42% per year) than the US Diagnostics & Research industry average (16.12%)
Forecast
SYNH's earnings are forecast to grow faster (31.42% per year) than the US market average (18.62%)
Forecast
SYNH's earnings are forecast to grow faster (31.42% per year) than the risk-free savings rate (1.5%)
Forecast

SYNH revenue growth forecast

How is SYNH forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
8.74%
Industry
11.42%
Market
12.37%
SYNH's revenues are forecast to grow slower (8.74% per year) than the US Diagnostics & Research industry average (11.42%)
Forecast
SYNH's revenues are forecast to grow slower (8.74% per year) than the US market average (12.37%)
Forecast

Syneos Health Stock Forecast FAQ

Is Syneos Health Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: SYNH) stock is to Strong Buy SYNH stock.

Out of 7 analysts, 4 (57.14%) are recommending SYNH as a Strong Buy, 2 (28.57%) are recommending SYNH as a Buy, 1 (14.29%) are recommending SYNH as a Hold, 0 (0%) are recommending SYNH as a Sell, and 0 (0%) are recommending SYNH as a Strong Sell.

What is SYNH's earnings growth forecast for 2021-2023?

(NASDAQ: SYNH) Syneos Health's forecast annual earnings growth rate of 31.42% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 16.12%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 18.62%.

Syneos Health's earnings in 2021 is $235,931,000.On average, 3 Wall Street analysts forecast SYNH's earnings for 2021 to be $400,479,783, with the lowest SYNH earnings forecast at $399,444,951, and the highest SYNH earnings forecast at $401,514,614. On average, 3 Wall Street analysts forecast SYNH's earnings for 2022 to be $470,848,323, with the lowest SYNH earnings forecast at $450,151,694, and the highest SYNH earnings forecast at $488,440,459.

In 2023, SYNH is forecast to generate $524,659,560 in earnings, with the lowest earnings forecast at $524,659,560 and the highest earnings forecast at $524,659,560.

What is SYNH's revenue growth forecast for 2021-2023?

(NASDAQ: SYNH) Syneos Health's forecast annual revenue growth rate of 8.74% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 11.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.37%.

Syneos Health's revenue in 2021 is $4,730,379,000.On average, 4 Wall Street analysts forecast SYNH's revenue for 2021 to be $542,799,121,373, with the lowest SYNH revenue forecast at $542,340,691,027, and the highest SYNH revenue forecast at $543,472,796,666. On average, 4 Wall Street analysts forecast SYNH's revenue for 2022 to be $588,425,979,641, with the lowest SYNH revenue forecast at $575,718,145,583, and the highest SYNH revenue forecast at $600,515,812,338.

In 2023, SYNH is forecast to generate $627,582,761,046 in revenue, with the lowest revenue forecast at $624,336,598,177 and the highest revenue forecast at $630,829,027,399.

What is SYNH's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: SYNH) forecast ROA is 7.46%, which is lower than the forecast US Diagnostics & Research industry average of 15.95%.

What is SYNH's Price Target?

According to 7 Wall Street analysts that have issued a 1 year SYNH price target, the average SYNH price target is $90.86, with the highest SYNH stock price forecast at $104.00 and the lowest SYNH stock price forecast at $75.00.

On average, Wall Street analysts predict that Syneos Health's share price could stay at $90.86 by Aug 10, 2022. The average Syneos Health stock price prediction forecasts a potential downside of N/A from the current SYNH share price of $96.31.

What is SYNH's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: SYNH) Syneos Health's current Earnings Per Share (EPS) is $2.26. On average, analysts forecast that SYNH's EPS will be $3.87 for 2021, with the lowest EPS forecast at $3.86, and the highest EPS forecast at $3.88. On average, analysts forecast that SYNH's EPS will be $4.55 for 2022, with the lowest EPS forecast at $4.35, and the highest EPS forecast at $4.72. In 2023, SYNH's EPS is forecast to hit $5.07 (min: $5.07, max: $5.07).

What is SYNH's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: SYNH) forecast ROE is 18.47%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.